Affimed to Report 3rd Quarter 2020 Financial Results & Corporate Update November 10, 2020

NEXT STORY
Precision BioSciences to Report Third Quarter 2020 Financial Results on November 10, 2020
PREV STORY
Health Canada Approves Canada’s First HIV Self Test
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rhythm Pharmaceuticals Announces First Patients Dosed in DAYBREAK and Weekly Trials Evaluating Setmelanotide for Rare Genetic Diseases of Obesity

author_avatar
NASDAQ Market News

Reata Pharmaceuticals, Inc. Announces First Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs

author_avatar
NASDAQ Market News

Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn’s Disease Patients

author_avatar
NASDAQ Market News